位置:首页 > 蛋白库 > CGL2_COPCI
CGL2_COPCI
ID   CGL2_COPCI              Reviewed;         150 AA.
AC   Q9P4R8; Q92214;
DT   23-NOV-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   03-AUG-2022, entry version 92.
DE   RecName: Full=Galectin-2;
DE   AltName: Full=Cgl-II;
DE   AltName: Full=Galectin II;
GN   Name=Cgl2;
OS   Coprinopsis cinerea (Inky cap fungus) (Hormographiella aspergillata).
OC   Eukaryota; Fungi; Dikarya; Basidiomycota; Agaricomycotina; Agaricomycetes;
OC   Agaricomycetidae; Agaricales; Psathyrellaceae; Coprinopsis.
OX   NCBI_TaxID=5346;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 1-20, FUNCTION, AND MASS
RP   SPECTROMETRY.
RC   STRAIN=JR52;
RX   PubMed=8999822; DOI=10.1074/jbc.272.3.1514;
RA   Cooper D.N.W., Boulianne R.P., Charlton S., Farrell E.M., Sucher A.,
RA   Lu B.C.;
RT   "Fungal galectins, sequence and specificity of two isolectins from Coprinus
RT   cinereus.";
RL   J. Biol. Chem. 272:1514-1521(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND SUBCELLULAR LOCATION.
RC   STRAIN=AmutBmut;
RX   PubMed=10931889; DOI=10.1099/00221287-146-8-1841;
RA   Boulianne R.P., Liu Y., Aebi M., Lu B.C., Kuees U.;
RT   "Fruiting body development in Coprinus cinereus: regulated expression of
RT   two galectins secreted by a non-classical pathway.";
RL   Microbiology 146:1841-1853(2000).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) IN COMPLEX WITH LACTOSE AND SUBSTRATE
RP   ANALOGS, FUNCTION, SUBUNIT, AND MUTAGENESIS OF ARG-55; TRP-72; PRO-146;
RP   LEU-147 AND PRO-148.
RX   PubMed=15062091; DOI=10.1016/j.str.2004.03.002;
RA   Walser P.J., Haebel P.W., Kuenzler M., Sargent D., Kuees U., Aebi M.,
RA   Ban N.;
RT   "Structure and functional analysis of the fungal galectin CGL2.";
RL   Structure 12:689-702(2004).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) IN COMPLEX WITH SUBSTRATE ANALOG,
RP   FUNCTION, AND MUTAGENESIS OF TRP-72.
RX   PubMed=20062796; DOI=10.1371/journal.ppat.1000717;
RA   Butschi A., Titz A., Waelti M.A., Olieric V., Paschinger K., Noebauer K.,
RA   Guo X., Seeberger P.H., Wilson I.B., Aebi M., Hengartner M.O., Kuenzler M.;
RT   "Caenorhabditis elegans N-glycan core beta-galactoside confers sensitivity
RT   towards nematotoxic fungal galectin CGL2.";
RL   PLoS Pathog. 6:E1000717-E1000717(2010).
CC   -!- FUNCTION: Binds lactose (PubMed:8999822, PubMed:15062091). May play a
CC       role in fruiting body formation (PubMed:8999822). Displays toxicity
CC       towards the nematode C.elegans by binding to a specific Gal-beta-1,4-
CC       Fuc-alpha-1,6 modification of N-glycan cores on C.elegans intestinal
CC       cells (PubMed:20062796). {ECO:0000269|PubMed:15062091,
CC       ECO:0000269|PubMed:20062796, ECO:0000269|PubMed:8999822}.
CC   -!- SUBUNIT: Homotetramer. Oligomerization is required for carbohydrate
CC       binding. {ECO:0000269|PubMed:15062091}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000269|PubMed:10931889}. Secreted, cell wall
CC       {ECO:0000269|PubMed:10931889}. Endomembrane system
CC       {ECO:0000269|PubMed:10931889}. Note=Detected in extracellular matrix,
CC       cell wall and cytoplasmic membrane-bound bodies.
CC   -!- MASS SPECTROMETRY: Mass=16672; Mass_error=1.2; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:8999822};
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=CGL2;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_oth_Stlect_379";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U64676; AAB06178.1; -; mRNA.
DR   EMBL; AF130360; AAF34732.1; -; Genomic_DNA.
DR   PDB; 1UL9; X-ray; 2.22 A; A/B=1-150.
DR   PDB; 1ULC; X-ray; 2.60 A; A/B=1-150.
DR   PDB; 1ULD; X-ray; 2.10 A; A/B/C/D=1-150.
DR   PDB; 1ULE; X-ray; 2.15 A; A/B=1-150.
DR   PDB; 1ULF; X-ray; 2.36 A; A/B=1-150.
DR   PDB; 1ULG; X-ray; 2.20 A; A/B/C/D=1-150.
DR   PDB; 2WKK; X-ray; 1.50 A; A/B/C/D=1-150.
DR   PDBsum; 1UL9; -.
DR   PDBsum; 1ULC; -.
DR   PDBsum; 1ULD; -.
DR   PDBsum; 1ULE; -.
DR   PDBsum; 1ULF; -.
DR   PDBsum; 1ULG; -.
DR   PDBsum; 2WKK; -.
DR   AlphaFoldDB; Q9P4R8; -.
DR   SMR; Q9P4R8; -.
DR   UniLectin; Q9P4R8; -.
DR   VEuPathDB; FungiDB:CC1G_05005; -.
DR   VEuPathDB; FungiDB:CC2G_013120; -.
DR   EvolutionaryTrace; Q9P4R8; -.
DR   GO; GO:0012505; C:endomembrane system; IEA:UniProtKB-SubCell.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   CDD; cd00070; GLECT; 1.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR001079; Galectin_CRD.
DR   Pfam; PF00337; Gal-bind_lectin; 1.
DR   SMART; SM00276; GLECT; 1.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   PROSITE; PS51304; GALECTIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell wall; Direct protein sequencing; Extracellular matrix;
KW   Fruiting body; Lectin; Membrane; Secreted.
FT   CHAIN           1..150
FT                   /note="Galectin-2"
FT                   /id="PRO_0000076968"
FT   DOMAIN          9..141
FT                   /note="Galectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00639"
FT   BINDING         51
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:15062091,
FT                   ECO:0000269|PubMed:20062796, ECO:0007744|PDB:1ULC,
FT                   ECO:0007744|PDB:1ULD, ECO:0007744|PDB:1ULE,
FT                   ECO:0007744|PDB:1ULF, ECO:0007744|PDB:1ULG,
FT                   ECO:0007744|PDB:2WKK"
FT   BINDING         55
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:15062091,
FT                   ECO:0000269|PubMed:20062796, ECO:0007744|PDB:1ULC,
FT                   ECO:0007744|PDB:1ULD, ECO:0007744|PDB:1ULE,
FT                   ECO:0007744|PDB:1ULF, ECO:0007744|PDB:1ULG,
FT                   ECO:0007744|PDB:2WKK"
FT   BINDING         64
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:15062091,
FT                   ECO:0000269|PubMed:20062796, ECO:0007744|PDB:1ULC,
FT                   ECO:0007744|PDB:1ULD, ECO:0007744|PDB:1ULE,
FT                   ECO:0007744|PDB:1ULF, ECO:0007744|PDB:1ULG,
FT                   ECO:0007744|PDB:2WKK"
FT   BINDING         75
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:15062091,
FT                   ECO:0000269|PubMed:20062796, ECO:0007744|PDB:1ULG"
FT   BINDING         77
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:20062796"
FT   MUTAGEN         55
FT                   /note="R->A: Completely abolishes carbohydrate binding.
FT                   Loss of toxicity towards C.elegans."
FT                   /evidence="ECO:0000269|PubMed:15062091,
FT                   ECO:0000269|PubMed:20062796"
FT   MUTAGEN         72
FT                   /note="W->G: Completely abolishes carbohydrate binding."
FT                   /evidence="ECO:0000269|PubMed:15062091"
FT   MUTAGEN         146
FT                   /note="P->G: Reduces the stability of the tetrameric
FT                   structure."
FT                   /evidence="ECO:0000269|PubMed:15062091"
FT   MUTAGEN         147
FT                   /note="L->S: Reduces the stability of the tetrameric
FT                   structure."
FT                   /evidence="ECO:0000269|PubMed:15062091"
FT   MUTAGEN         148
FT                   /note="P->G: Reduces the stability of the tetrameric
FT                   structure."
FT                   /evidence="ECO:0000269|PubMed:15062091"
FT   CONFLICT        99
FT                   /note="R -> K (in Ref. 1; AAB06178)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        121
FT                   /note="A -> T (in Ref. 1; AAB06178)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        129
FT                   /note="N -> S (in Ref. 1; AAB06178)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        143
FT                   /note="L -> S (in Ref. 1; AAB06178)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        146
FT                   /note="P -> A (in Ref. 1; AAB06178)"
FT                   /evidence="ECO:0000305"
FT   STRAND          2..5
FT                   /evidence="ECO:0007829|PDB:2WKK"
FT   STRAND          9..17
FT                   /evidence="ECO:0007829|PDB:2WKK"
FT   STRAND          22..26
FT                   /evidence="ECO:0007829|PDB:2WKK"
FT   STRAND          37..42
FT                   /evidence="ECO:0007829|PDB:2WKK"
FT   STRAND          48..55
FT                   /evidence="ECO:0007829|PDB:2WKK"
FT   TURN            56..59
FT                   /evidence="ECO:0007829|PDB:2WKK"
FT   STRAND          60..66
FT                   /evidence="ECO:0007829|PDB:2WKK"
FT   STRAND          68..70
FT                   /evidence="ECO:0007829|PDB:1ULG"
FT   STRAND          76..79
FT                   /evidence="ECO:0007829|PDB:2WKK"
FT   STRAND          86..88
FT                   /evidence="ECO:0007829|PDB:2WKK"
FT   STRAND          90..95
FT                   /evidence="ECO:0007829|PDB:2WKK"
FT   STRAND          97..103
FT                   /evidence="ECO:0007829|PDB:2WKK"
FT   STRAND          105..107
FT                   /evidence="ECO:0007829|PDB:2WKK"
FT   STRAND          110..113
FT                   /evidence="ECO:0007829|PDB:2WKK"
FT   STRAND          120..129
FT                   /evidence="ECO:0007829|PDB:2WKK"
FT   STRAND          134..143
FT                   /evidence="ECO:0007829|PDB:2WKK"
SQ   SEQUENCE   150 AA;  16748 MW;  EA6914570761AD7B CRC64;
     MLYHLFVNNQ VKLQNDFKPE SVAAIRSSAF NSKGGTTVFN FLSAGENILL HISIRPGENV
     IVFNSRLKNG AWGPEERIPY AEKFRPPNPS ITVIDHGDRF QIRFDYGTSI YYNKRIKENA
     AAIAYNAENS LFSSPVTVDV HGLLPPLPPA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024